Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
group | 0.500 | None | 0.867 | 60 | 0 | 1997 | 2019 | ||||||||
|
stearoyl-CoA desaturase | 0.490 | 0.808 | 0.97 |
|
group | 0.500 | None | 1.000 | 3 | 0 | 2002 | 2005 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.400 | None | 0.945 | 711 | 7 | 1990 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
group | 0.400 | None | 0.976 | 206 | 3 | 1988 | 2020 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.400 | None | 0.969 | 130 | 1 | 1984 | 2020 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
group | 0.400 | None | 0.975 | 81 | 0 | 1996 | 2020 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
group | 0.400 | None | 0.962 | 79 | 0 | 1990 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
group | 0.400 | None | 0.911 | 79 | 0 | 1994 | 2018 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
group | 0.400 | None | 0.957 | 70 | 4 | 1982 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
group | 0.400 | None | 0.982 | 57 | 0 | 1994 | 2019 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
group | 0.400 | None | 0.962 | 52 | 2 | 1983 | 2019 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
group | 0.400 | None | 0.958 | 48 | 7 | 1991 | 2019 | ||||||||
|
cadherin 1 | 0.401 | 0.808 | 0.15 |
|
group | 0.400 | None | 1.000 | 47 | 0 | 1994 | 2019 | ||||||||
|
epithelial cell adhesion molecule | 0.451 | 0.885 | 1.3E-07 |
|
group | 0.400 | None | 1.000 | 38 | 0 | 1989 | 2019 | ||||||||
|
fragile histidine triad diadenosine triphosphatase | 0.444 | 0.846 | 5.7E-03 |
|
group | 0.400 | None | 0.909 | 33 | 0 | 1996 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
group | 0.400 | None | 0.970 | 33 | 0 | 1989 | 2019 | ||||||||
|
progesterone receptor | 0.426 | 0.885 | 5.1E-02 |
|
group | 0.400 | None | 0.970 | 33 | 0 | 1989 | 2018 | ||||||||
|
tumor protein p63 | 0.362 | 0.769 | 1.00 |
|
group | 0.400 | None | 1.000 | 30 | 1 | 2000 | 2019 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
group | 0.400 | None | 0.966 | 29 | 1 | 1989 | 2015 | ||||||||
|
von Hippel-Lindau tumor suppressor | 0.443 | 0.846 | 8.0E-02 |
|
group | 0.400 | None | 1.000 | 24 | 0 | 1994 | 2019 | ||||||||
|
GATA binding protein 3 | 0.415 | 0.846 | 0.90 |
|
group | 0.400 | None | 1.000 | 23 | 0 | 2005 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
group | 0.400 | None | 1.000 | 23 | 0 | 1990 | 2019 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
group | 0.400 | None | 0.882 | 17 | 0 | 2001 | 2019 | ||||||||
|
cyclin dependent kinase 4 | 0.412 | 0.808 | 6.3E-02 |
|
group | 0.400 | None | 1.000 | 15 | 0 | 1996 | 2018 | ||||||||
|
fibronectin 1 | 0.365 | 0.962 | 1.4E-03 |
|
group | 0.400 | None | 1.000 | 13 | 1 | 1992 | 2019 |